scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1049497826 |
P356 | DOI | 10.1186/1753-2000-3-11 |
P932 | PMC publication ID | 2666637 |
P698 | PubMed publication ID | 19298659 |
P5875 | ResearchGate publication ID | 24212549 |
P50 | author | Maria Pagano | Q47808260 |
Robert L Findling | Q90314248 | ||
Christine A Demeter | Q105682824 | ||
P2093 | author name string | Michael D Reed | |
Jacqui Lingler | |||
Nora K McNamara | |||
Robert J Stansbrey | |||
Denise Bedoya | |||
Jon E Faber | |||
P2860 | cites work | Efficacy of antidepressants in juvenile depression: meta-analysis | Q22255557 |
An Inventory for Measuring Depression | Q26778503 | ||
A children's global assessment scale (CGAS) | Q28271291 | ||
Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation | Q28307938 | ||
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data | Q29616031 | ||
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials | Q29619671 | ||
The use of antidepressants to treat depression in children and adolescents | Q34257369 | ||
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial | Q34341755 | ||
Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students | Q34360713 | ||
Childhood and adolescent depression: a review of the past 10 years. Part I. | Q34736609 | ||
Course and outcome of child and adolescent major depressive disorder | Q34834286 | ||
The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression | Q36428441 | ||
The B-Value: A Tool for Monitoring Data | Q36453425 | ||
Psychosocial risk factors for future adolescent suicide attempts | Q41036796 | ||
The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials | Q42638750 | ||
Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial | Q42662291 | ||
Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial | Q44168453 | ||
Characteristics of suicide attempters in a population-based sample of Dutch adolescents | Q44594867 | ||
Common problems and coping strategies. II: Findings with adolescent suicide attempters | Q45764098 | ||
A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders | Q46913407 | ||
Suicidality in pediatric patients treated with antidepressant drugs | Q46977975 | ||
Hopelessness and suicidal ideation among adolescents in two cultures | Q47281715 | ||
Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients | Q47355076 | ||
The measurement of pessimism: the hopelessness scale. | Q47359395 | ||
Unipolar depression in adolescents: clinical outcome in adulthood | Q48820908 | ||
Psychological autopsy of completed suicide in children and adolescents | Q49201340 | ||
A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. | Q50924850 | ||
Age- and sex-related risk factors for adolescent suicide. | Q51979337 | ||
Incidence of major depressive disorder and dysthymia in young adolescents. | Q52002650 | ||
Addiction-risk behaviours and suicide attempts in adolescents. | Q52276001 | ||
Fluoxetine in drug-dependent delinquents with major depression: an open trial. | Q53966884 | ||
Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation | Q70550378 | ||
Dysthymia characteristic of heavy alcohol use in depressed adolescents | Q70597395 | ||
Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial | Q73665552 | ||
A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study | Q78439763 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | placebo | Q269829 |
fluoxetine | Q422244 | ||
teenager | Q1492760 | ||
placebo-controlled trial | Q108853737 | ||
P304 | page(s) | 11 | |
P577 | publication date | 2009-03-19 | |
P1433 | published in | Child and Adolescent Psychiatry and Mental Health | Q15767228 |
P1476 | title | The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial | |
P478 | volume | 3 |
Q36530819 | A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention |
Q34124607 | Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence? |
Q38602146 | Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis. |
Q38237466 | Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis |
Q35878089 | Evaluation of a spirituality informed e-mental health tool as an intervention for major depressive disorder in adolescents and young adults - a randomized controlled pilot trial |
Q47582630 | Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder |
Q35582292 | Generalizability of clinical trials for cannabis dependence to community samples |
Q36151947 | Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders |
Q24202873 | Newer generation antidepressants for depressive disorders in children and adolescents |
Q24187250 | Pharmacotherapies for cannabis dependence |
Q61440575 | Pharmacotherapies for cannabis dependence |
Q37574339 | Pharmacotherapy for Substance Use Disorders in Youths |
Q90393501 | Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis |
Q37417696 | Using Bayes factors for testing hypotheses about intervention effectiveness in addictions research |